Retraction of a randomized controlled trial on bifidobacterium bifidum's effects on respiratory tract infections and atopy in cesarean-born newborns, suggesting potential data issues.
The journal retracts the article, "Effect of Bifidobacterium bifidum Supplementation in Newborns Born from Cesarean Section on Atopy, Respiratory Tract Infections, and Dyspeptic Syndromes: A Multicenter, Randomized, and Controlled Clinical Trial" [...].
No takes yet. Share an insight, caveat, or question.
Bellomo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: